DAN A23 (RANITIDINE 300 mg)
Pill imprint DAN A23 has been identified as Ranitidine hydrochloride 300 mg.
Ranitidine is used in the treatment of gerd; gastric ulcer maintenance treatment; indigestion; stomach ulcer; stress ulcer prophylaxis (and more), and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 300 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for DAN A23 (RANITIDINE 300 mg)
Ranitidine hydrochloride
- Imprint:
-
DAN A23
- Strength:
- 300 mg
- Color:
- Yellow
- Shape:
- Elliptical / Oval
- Availability:
- Rx and/or OTC
- Drug Class:
- H2 antagonists
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Schein
More resources
Ranitidine hydrochloride is associated with the treatment of:
Search Again
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...
